James J. Sollome, Ph.D.
Affiliations: | 2014 | Pharmacology & Toxicology | University of Arizona, Tucson, AZ |
Area:
Pharmacology, Toxicology, OncologyGoogle:
"James Sollome"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Richard R. Vaillancourt | grad student | 2014 | University of Arizona | |
| (Heregulin activates a novel HER2/HER3-MTK1-GIT1/ERK1/2 MAPK signaling pathway.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Garcia-Flores AE, Sollome JJ, Thavathiru E, et al. (2019) HER2/HER3 regulates lactate secretion and expression of lactate receptor mRNA through the MAP3K4 associated protein GIT1. Scientific Reports. 9: 10823 |
| Sollome JJ, Thavathiru E, Camenisch TD, et al. (2014) HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4). Cellular Signalling. 26: 70-82 |
| Druwe IL, Sollome JJ, Sanchez-Soria P, et al. (2012) Arsenite activates NFκB through induction of C-reactive protein. Toxicology and Applied Pharmacology. 261: 263-70 |
| Hays AM, Lantz RC, Rodgers LS, et al. (2008) Arsenic-induced decreases in the vascular matrix. Toxicologic Pathology. 36: 805-17 |
| Pysher MD, Sollome JJ, Regan S, et al. (2007) Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic. Toxicology and Applied Pharmacology. 224: 39-48 |